Compugen stock maintained at Buy by H.C. Wainwright, $4 target

H.C. Wainwright reiterates Janux Therapeutics stock rating at buy

Investing.com · News 7m ago

Cardinal Infrastructure stock tumbles 33% on earnings miss, margin woes

Investing.com · News 8m ago

Traws Pharma completes ratutrelvir COVID-19 study

Investing.com · News 8m ago

Beamr projects 50% revenue growth for 2026

Investing.com · News 8m ago

Playstudios launches $15 million share buyback tender offer

Investing.com · News 8m ago

Praise Was Heaped on Jensen Huang. That Might Be Part of the Problem.

Dow Jones · Markets 9m ago

Foreign inflows lift Indian stocks' dollar returns above rupee gains as currency rebounds

LiveMint · Markets 10m ago

Page Industries shares plunge 13% as higher RM costs hit Q2 profitability; can festive demand drive a recovery?

LiveMint · Markets 13m ago

Forgent Power shares fall 4% on full-year guidance below estimates

Investing.com · Investing_news 13m ago

Bit Digital stock falls 9% on revenue miss despite earnings beat

Investing.com · Investing_news 17m ago